SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Jensen Carl)
 

Search: WFRF:(Jensen Carl) > Increased retinopat...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003801naa a2200457 4500
001oai:lup.lub.lu.se:e0706f09-ec19-4576-abf3-729d55e3ca06
003SwePub
008160401s2009 | |||||||||||000 ||eng|
024a https://lup.lub.lu.se/record/14618892 URI
024a https://doi.org/10.1111/j.1755-3768.2008.01300.x2 DOI
040 a (SwePub)lu
041 a engb eng
042 9 SwePub
072 7a art2 swepub-publicationtype
072 7a ref2 swepub-contenttype
100a Fosmark, Dag S.4 aut
2451 0a Increased retinopathy occurrence in type 1 diabetes patients with increased serum levels of the advanced glycation endproduct hydroimidazolone
264 1b Wiley,c 2009
520 a Purpose: We aimed to investigate associations between serum levels of the advanced glycation endproduct methylglyoxal-derived hydroimidazolone (MG-H1) and retinopathy in a sample of patients with type 1 diabetes. Methods: We conducted a cross-sectional study in a Scandinavian ophthalmology outpatient clinic on 61 randomly selected patients with type 1 diabetes. Blood samples and retinal photographs were taken at the same visit. Serum levels of hydroimidazolone immunoreactivity were determined using an immunoassay, and levels of retinopathy were determined from seven standard field stereo photographs of each eye according to the ETDRS method. Results were compared between patients with and without retinopathy. Results: Hydroimidazolone quartiles were significantly associated with retinopathy (p = 0.013). The most profound increase in occurrence of retinopathy was observed from the lowest to the second-lowest hydroimidazolone quartile. Adjusted for duration of diabetes using logistic regression, a significant difference in the presence of retinopathy was found when comparing the lowest quartile with the rest (p = 0.022). Conclusions: In our patients with type 1 diabetes, serum levels of hydroimidazolone were found to be associated with retinopathy. This is in keeping with findings in a larger sample of patients with type 2 diabetes.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Endokrinologi och diabetes0 (SwePub)302052 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Endocrinology and Diabetes0 (SwePub)302052 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Oftalmologi0 (SwePub)302172 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Ophthalmology0 (SwePub)302172 hsv//eng
653 a MG-H1
653 a (MG)
653 a methylglyoxal
653 a advanced glycation endproducts (AGEs)
653 a hydroimidazolone
653 a retinopathy
653 a type 1 diabetes
700a Berg, Jens P.4 aut
700a Jensen, Aase-Brith4 aut
700a Sandvik, Leiv4 aut
700a Agardh, Elisabetu Lund University,Lunds universitet,Institutionen för kliniska vetenskaper, Malmö,Medicinska fakulteten,Oftalmologi (Malmö),Forskargrupper vid Lunds universitet,Department of Clinical Sciences, Malmö,Faculty of Medicine,Ophthalmology (Malmö),Lund University Research Groups4 aut0 (Swepub:lu)ofta-eag
700a Agardh, Carl-Davidu Lund University,Lunds universitet,Institutionen för kliniska vetenskaper, Malmö,Medicinska fakulteten,Department of Clinical Sciences, Malmö,Faculty of Medicine4 aut0 (Swepub:lu)endo-cag
700a Hanssen, Kristian F.4 aut
710a Institutionen för kliniska vetenskaper, Malmöb Medicinska fakulteten4 org
773t Acta Ophthalmologicad : Wileyg 87:5, s. 498-500q 87:5<498-500x 1755-3768x 1755-375X
856u http://dx.doi.org/10.1111/j.1755-3768.2008.01300.xy FULLTEXT
8564 8u https://lup.lub.lu.se/record/1461889
8564 8u https://doi.org/10.1111/j.1755-3768.2008.01300.x

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view